Thani Jambulingam - Jan 29, 2024 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Thani Jambulingam
Stock symbol
VRPX
Transactions as of
Jan 29, 2024
Transactions value $
$0
Form type
4
Date filed
1/31/2024, 04:25 PM
Previous filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +25K $0.00 25K Jan 29, 2024 Common Stock 25K $0.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis for 12 months commencing one year after the date of grant.

Remarks:

Exhibit 24.1 - Power of Attorney (Thani Jambulingam)